beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.
Three of four clinical isolates of Branhamella catarrhalis from Belgium produced a beta-lactamase identical to enzymes previously reported to occur in French and British isolates of this organism. One strain, however, produced a new type of beta-lactamase. Both beta-lactamase types were readily inhibited by low concentrations of clavulanic acid.
D000332:Aerobiosis; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D019818:Clavulanic Acid; D007525:Isoelectric Focusing; D009343:Neisseria / Q000201:enzymology*; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000378:metabolism*; D047090:beta-Lactams / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; D019818:Clavulanic Acid; D001618:beta-Lactamases